WHIM syndrome

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 20:23, 11 August 2023 by Warner-admin (talk | contribs) (Text replacement - ":Section editor transclusions|" to ":Editorial board transclusions|")
Jump to navigation Jump to search

Section editor
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Vanderbilt University
Nashville, TN, USA

LinkedIn

WHIM: Warts, Hypogammaglobulinemia, Infections, Myelokathexis

1 regimens on this page
1 variants on this page


All lines of therapy

Plerixafor monotherapy

Regimen

Study Evidence
McDermott et al. 2019 Pilot, fewer than 20 pts

Growth factor therapy

References

  1. McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH 3rd, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM. Plerixafor for the treatment of WHIM syndrome. N Engl J Med. 2019 Jan 10;380(2):163-170. link to original article link to PMC article PubMed